Andreas von Deimling
Co-created the DNA methylation classifier that changed how brain tumours are diagnosed worldwide.
Andreas von Deimling, with Stefan Pfister and David Capper, developed the Heidelberg methylation-based classifier for central nervous system tumours, now embedded in the WHO classification.
| Title | Journal | Year |
|---|---|---|
| DNA methylation-based classification of central nervous system tumours | Nature | 2018 |
Pages like this
not linked directly; found by shared links- PersonStefan Pfister
Shares Heidelberg University Hospital / NCT / DKFZ, German Cancer Research Center (DKFZ), DNA methylation profiling, Glioma & glioblastoma.
- PersonStefan Fröhling
Shares Heidelberg University Hospital / NCT / DKFZ, German Cancer Research Center (DKFZ).
- TrialINDIGO
Shares IDH1 / IDH2, Glioma & glioblastoma.
- InstitutionDuke Cancer Institute
Shares IDH1 / IDH2, Glioma & glioblastoma.
- InstitutionNCT/UCC Dresden – University Hospital Carl Gustav Carus
Shares Heidelberg University Hospital / NCT / DKFZ, German Cancer Research Center (DKFZ).
- InstitutionDeutsche Krebshilfe
Shares Heidelberg University Hospital / NCT / DKFZ, German Cancer Research Center (DKFZ).
- PersonUwe Haberkorn
Shares Heidelberg University Hospital / NCT / DKFZ, German Cancer Research Center (DKFZ).
- InstitutionUniversity Cancer Center Frankfurt (UCT)
Shares German Cancer Research Center (DKFZ), Glioma & glioblastoma.